Genome-Wide Analysis of ChREBP Binding Sites on Male Mouse Liver and White Adipose Chromatin

Endocrinology
N PoungvarinL Chan

Abstract

Glucose is an essential nutrient that directly regulates the expression of numerous genes in liver and adipose tissue. The carbohydrate response element-binding protein (ChREBP) links glucose as a signaling molecule to multiple glucose-dependent transcriptional regulatory pathways, particularly genes involved in glycolytic and lipogenic processes. In this study, we used chromatin immunoprecipitation followed by next-generation sequencing to identify specific ChREBP binding targets in liver and white adipose tissue. We found a large number of ChREBP binding sites, which are attributable to 5825 genes in the liver, 2418 genes in white adipose tissue, and 5919 genes in both tissues. The majority of these target genes were involved in known metabolic processes. Pathways in insulin signaling, the adherens junction, and cancers were among the top 5 pathways in both tissues. Motif analysis revealed a consensus sequence CAYGYGnnnnnCRCRTG that was commonly shared by ChREBP binding sites. Putative ChREBP binding sequences were enriched on promoters of genes involved in insulin signaling pathway, insulin resistance, and tumorigenesis.

References

May 8, 2001·The Journal of Biological Chemistry·B L O'CallaghanH C Towle
Jul 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·H YamashitaK Uyeda
Nov 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·T KawaguchiK Uyeda
Jun 5, 2002·Genome Research·W James KentDavid Haussler
May 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Katsumi IizukaKosaku Uyeda
May 18, 2006·American Journal of Physiology. Endocrinology and Metabolism·Katsumi IizukaKosaku Uyeda
Aug 4, 2006·The Journal of Biological Chemistry·Lin MaHoward C Towle
Nov 16, 2006·American Journal of Physiology. Endocrinology and Metabolism·Kim B PedersenDonald K Scott
Jun 15, 2007·Current Opinion in Clinical Nutrition and Metabolic Care·Emmanuelle MeugnierHubert Vidal
Jul 8, 2008·Biochemical and Biophysical Research Communications·Katsumi Iizuka, Yukio Horikawa
Aug 1, 2008·Journal of Virology·Mandana MansouriKlaus Früh
Sep 19, 2008·Genome Biology·Yong ZhangX Shirley Liu
Aug 8, 2009·FEBS Letters·Katsumi IizukaYukio Horikawa
Dec 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Xuemei TongCraig B Thompson
Apr 13, 2010·Biochemical and Biophysical Research Communications·Ming V LiLawrence Chan
Oct 12, 2010·Biochemical and Biophysical Research Communications·Gabriela da Silva XavierIsabelle Leclerc
Apr 14, 2011·Bioinformatics·Philip Machanick, Timothy L Bailey
Aug 17, 2011·Nucleic Acids Research·Morgane Thomas-ChollierJacques van Helden
Aug 23, 2011·Biochemical and Biophysical Research Communications·Katsumi IizukaYukio Horikawa
Dec 27, 2011·Biochemical and Biophysical Research Communications·Katsumi IizukaYukio Horikawa
Mar 10, 2012·The Journal of Endocrinology·Isabelle LeclercNafeesa Noordeen
May 25, 2013·Nucleic Acids Research·Jing WangBing Zhang
Nov 7, 2013·Oxidative Medicine and Cellular Longevity·Hyun-Ae Seo, In-Kyu Lee

❮ Previous
Next ❯

Citations

Mar 10, 2018·Nutrients·Hiroyuki NiwaJun Takeda
Aug 9, 2018·The Journal of Biological Chemistry·Huabo WangEdward V Prochownik
May 20, 2016·Nature Communications·Akash K KaushikArun Sreekumar
Jul 10, 2019·JCI Insight·Byungyong AhnDaniel P Kelly
Nov 24, 2019·Metabolites·Fabienne RajasGilles Mithieux
Jan 25, 2020·The Journal of Biological Chemistry·Tabassum MooniraLoranne Agius
Jul 11, 2020·The Biochemical Journal·James E MerrettChristopher G Proud
May 19, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Joanne A HoogerlandMaaike H Oosterveer
Jun 27, 2019·PloS One·Huabo WangEdward V Prochownik
Sep 1, 2017·Nature Communications·Steffi HeidenreichMichael Schupp
Jun 27, 2019·Journal of Cellular Physiology·Mahesh S KrishnaAbdul Jaleel
Jul 6, 2019·Frontiers in Genetics·Paula Ortega-Prieto, Catherine Postic
Nov 4, 2015·Physiology·Floriane BarailleCatherine Postic
Feb 23, 2020·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yu LeiMaaike H Oosterveer
Nov 24, 2020·American Journal of Physiology. Endocrinology and Metabolism·Laura Velázquez-VillegasVictor M Ortiz-Ortega
Oct 8, 2020·The Journal of Biological Chemistry·Steffi HeidenreichMichael Schupp
Jan 18, 2021·The Journal of Biological Chemistry·Steffi HeidenreichMichael Schupp
Apr 5, 2021·The Journal of Biological Chemistry·Liora S KatzMark A Herman
Feb 24, 2021·The Journal of Clinical Endocrinology and Metabolism·Federico OldoniHelen H Hobbs
Apr 24, 2021·Genes & Development·Younghoon JangKai Ge
May 20, 2021·Chinese Medical Journal·Ya-Nan ShiWeiping J Zhang
May 21, 2020·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·Helen SievertHenriette Kirchner
Nov 21, 2015·Genes & Development·Liam C HuntFabio Demontis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.